Form 4 holding
SVP, GEN COUNSEL & CORP SEC
Vaxcyte, Inc.
- Security class
- Common Stock
- Shares / value
- 41,620
- Estimated value
- $3,012,039
- Report date
- 05 Mar 2025
- Price
- $72.37
- Ownership
- Direct
Mikhail Eydelman - SVP, GEN COUNSEL & CORP SEC at Vaxcyte, Inc.
Issuer-level insider activity
- Role
- Svp, Gen Counsel & Corp Sec
- Issuer ticker
- PCVX on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Mikhail Eydelman since 10 Sep 2025
Reported holdings for Mikhail Eydelman in Vaxcyte, Inc.
Form 4 holding
SVP, GEN COUNSEL & CORP SEC
Vaxcyte, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 144,497
- Estimated value
- Report date
- 05 Mar 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
SVP, GEN COUNSEL & CORP SEC
Vaxcyte, Inc.
- Security class
- Performance Stock Option (right to buy)
- Shares / value
- 26,125
- Estimated value
- Report date
- 07 Nov 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Mikhail Eydelman in Vaxcyte, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.